Indication

Heart Complications

1 clinical trial

1 product

Clinical trial

Phase 1 Open Label, Dose Escalation Trial of Intracoronary Infusion of NAN-101 in Subjects With NYHA Class III Heart Failure

Status: Recruiting, Estimated PCD: 2026-12-31

Product